If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArcontech Group Regulatory News (ARC)

Share Price Information for Arcontech Group (ARC)

Share Price is delayed by 15 minutes
Get Live Data
83.50    0.00 (0.00%)
Bid:
82.00
Ask:
85.00
Spread: 3.00 (3.659%)
Market Cap: £11.17m
ARC Live PriceLast checked at - London Stock Exchange

Intraday Arcontech Group Share Chart

Trading Update

29 Nov 2021 07:00

RNS Number : 7995T
Arcontech Group PLC
29 November 2021
 

ARCONTECH GROUP PLC

 

("Arcontech" or the "Company")

Trading Update

Arcontech (AIM: ARC), the provider of products and services for real-time financial market data processing and trading, announces that its trading performance has regrettably fallen below current market expectations due to one customer reducing its market data spend with the Company, and notification from another customer that it will not be renewing its contract from the start of second half of 2022. The two changes are unrelated and do not involve customers with Arcontech's core MVCS server-side solution. They instead reflect one customer greatly scaling back its market data team and market data requirements, and a second choosing not to renew its contract for one Arcontech product because it is switching to use a solution included in a legacy, bundled contract.

The Company is consequently revising its year end market guidance to reflect this net reduction of revenue. The reductions will take effect at the beginning of the second half of Arcontech's financial year and consequently will negatively impact revenue by annualised c.£300K, half of which will impact in the current financial year.

However, notwithstanding the above the Company senses an overall improvement in the business outlook which until now has seen growth affected by Covid. Its clients are now renewing interest in new business projects and the Company's sales pipeline continues to be healthy. The increasing opportunities to travel and cement new relationships also bode well for the future and our ability to recover lost ground. During the last year Arcontech has improved its offerings to provide more value and the quality of its solutions together with its ability to help reduce spend, positions the Company well to absorb any lost business and resume growth as the pipeline matures. Arcontech continues to be fully confident in the strength of the business and is working to leverage its cash reserves, when the opportunity arises.

Enquiries:

 

Arcontech Group plc

 020 7256 2300

Geoff Wicks, Chairman and Non-Executive Director

Matthew Jeffs, Chief Executive

finnCap Ltd (Nomad & Broker)

Carl Holmes/Tim Harper

 020 7220 0500

To access more information on the Group please visit: www.arcontech.com

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFEFFAAEFSEDF
Date   Source Headline
20th Sep 20107:00 amRNSDirector/PDMR Shareholding
26th Jul 20107:00 amRNSPreliminary Results
14th Jun 20101:27 pmRNSHolding(s) in Company
16th Apr 20107:00 amRNSExcelerator Version 3 Release
15th Apr 20106:20 pmRNSHolding(s) in Company
26th Mar 20107:00 amRNSHalf Yearly Report
14th Dec 20097:00 amRNSNew Contract
11th Dec 20097:00 amRNSNew Director of Sales and Marketing
27th Nov 20097:00 amRNSNew Contract
9th Nov 200911:04 amRNSHolding(s) in Company
9th Nov 200910:55 amRNSHolding(s) in Company
4th Nov 200912:21 pmRNSHolding(s) in Company
29th Oct 20094:35 pmRNSResult of AGM
8th Oct 20098:31 amRNSHolding(s) in Company
6th Oct 20097:00 amRNSProduct Launch
21st Sep 20097:00 amRNSFinal Results
21st Sep 20097:00 amRNSPlacing to raise ?1.55 million
14th Jul 20097:00 amRNSIssue of Deferred Consideration
15th Jun 20097:00 amRNSChange of Name of Nominated Adviser and Broker
15th May 20097:00 amRNSStatement re CityVision
29th Apr 20097:00 amRNSArcontech's Excelerator finds favour in Europe
25th Mar 200912:38 pmRNSDirector/PDMR Shareholding
20th Mar 20097:00 amRNSHalf Yearly Report
23rd Feb 20097:00 amRNSChange of Name
28th Nov 20087:00 amRNSFinal Results
15th Sep 20087:00 amRNSStatement re Arcontech
22nd May 200812:30 pmRNSSale of MT Information Base
17th Apr 200811:47 amRNSHolding(s) in Company
15th Apr 20082:43 pmRNSHolding(s) in Company
10th Apr 200810:51 amRNSHolding(s) in Company
10th Apr 20087:00 amRNSDirector/PDMR Shareholding
4th Apr 20085:39 pmRNSDirector/PDMR Shareholding
4th Apr 20087:01 amRNSAdditional Listing
31st Mar 20087:02 amRNSInterim Results
11th Mar 20087:02 amRNSLaunch of New Website
3rd Mar 20087:02 amRNSExpansion of StarNet
17th Jan 20086:21 pmRNSRe Contract - Replacement
16th Jan 20087:01 amRNSRe Contract
18th Dec 20077:01 amRNSDirectorate Change
13th Dec 20079:48 amRNSHolding(s) in Company
10th Dec 200711:14 amRNSHolding(s) in Company
4th Dec 20077:01 amRNSFinal Results
20th Sep 20079:30 amRNSContract Win
5th Sep 20071:53 pmRNSHolding(s) in Company
3rd Sep 20072:11 pmRNSAdditional Listing
7th Aug 20077:01 amRNSAcquisition
19th Jul 20077:00 amRNSNew Best Execution Tool on MT
12th Jul 20079:54 amRNSStatement re Trading on PLUS
22nd Mar 20072:30 pmRNSHolding(s) in Company
12th Mar 20077:01 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.